Detalhe da pesquisa
1.
Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
Hepatol Res
; 54(6): 562-574, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133587
2.
Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase.
Antimicrob Agents Chemother
; 54(8): 3179-86, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20498328
3.
Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
Hepatology
; 50(6): 1727-37, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19821486
4.
Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.
J Gastroenterol
; 45(5): 523-36, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20012654